The FGFR1 gene has been suggested as a target of YAP in cholangiocarcinoma, as chromatin immunoprecipitation assays demonstrated the simultaneous nuclear presence of TBX5-YAP complexes on the promoter region of FGFR1 [15]. The gene discussed is FGFR1; the disease is cholangiocarcinoma.